- Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill CNBC
- Pfizer Reports Earnings Tuesday. What to Expect. Barron’s
- Pfizer stock falls after profit beats but revenue misses, even as COVID-19 vaccine sales of $12.5 billion top forecasts MarketWatch
- Pfizer Forecast Misses Wall Street Views on Covid Product Sales Bloomberg
- Pfizer vaccine, pill forecasts miss estimates; shares fall 4% Reuters
- View Full Coverage on Google News